Literature DB >> 27063264

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.

Mehmet Sayiner1, Aaron Koenig1, Linda Henry1, Zobair M Younossi2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease with increasing prevalence, which can progress to cirrhosis and liver failure. Because of the obesity epidemic and increasing prevalence of metabolic syndrome, NAFLD and its progressive form, nonalcoholic steatohepatitis, are seen more commonly in different parts of the world. This article reviews the worldwide epidemiology of NAFLD and nonalcoholic steatohepatitis. The PubMed database was used to identify studies related to epidemiology of NAFLD in the adult population. It is estimated that the epidemic of obesity will continue to fuel the burden of NAFLD and its long-term complications.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; NAFLD; NASH; Prevalence

Mesh:

Year:  2015        PMID: 27063264     DOI: 10.1016/j.cld.2015.10.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  141 in total

Review 1.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Authors:  Hong Sheng Cheng; Wei Ren Tan; Zun Siong Low; Charlie Marvalim; Justin Yin Hao Lee; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

2.  Impact of miR-140 Deficiency on Non-Alcoholic Fatty Liver Disease.

Authors:  Benjamin Wolfson; Pang-Kuo Lo; Yuan Yao; Linhao Li; Hongbing Wang; Qun Zhou
Journal:  Mol Nutr Food Res       Date:  2018-06-12       Impact factor: 5.914

Review 3.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

5.  An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors.

Authors:  Suriyan Ponnusamy; Quynh T Tran; Thirumagal Thiyagarajan; Duane D Miller; Dave Bridges; Ramesh Narayanan
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-16

6.  Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.

Authors:  Pao-Yuan Lin; Chih-Hung Chen; Christopher Glenn Wallace; Kuan-Hung Chen; Chia-Lo Chang; Hong-Hwa Chen; Pei-Hsun Sung; Kun-Chen Lin; Sheung-Fat Ko; Cheuk-Kwan Sun; Hsueh-Wen Chang; Pei-Lin Shao; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

7.  Embryonic exposures to mono-2-ethylhexyl phthalate induce larval steatosis in zebrafish independent of Nrf2a signaling.

Authors:  Karilyn E Sant; Hadley M Moreau; Larissa M Williams; Haydee M Jacobs; Anna M Bowsher; Jason D Boisvert; Roxanna M Smolowitz; Jacob Pantazis; Kate Annunziato; Malina Nguyen; Alicia Timme-Laragy
Journal:  J Dev Orig Health Dis       Date:  2020-02-17       Impact factor: 2.401

8.  Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.

Authors:  Masataka Kanno; Kazunori Kawaguchi; Masao Honda; Rika Horii; Hajime Takatori; Tetsuro Shimakami; Kazuya Kitamura; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2019-02-01       Impact factor: 7.527

9.  Nonalcoholic Fatty Liver Disease Is a Susceptibility Factor for Perchloroethylene-Induced Liver Effects in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Yu-Syuan Luo; Yasuhiro Iwata; Kranti Konganti; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

10.  Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.

Authors:  Joshua S Winder; Brandon S Dudeck; Sarayna Schock; Jerome R Lyn-Sue; Randy S Haluck; Ann M Rogers
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.